• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.人乳头瘤病毒癌蛋白E6可使转录共激活因子人ADA3失活。
Mol Cell Biol. 2002 Aug;22(16):5801-12. doi: 10.1128/MCB.22.16.5801-5812.2002.
2
Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator.人乳头瘤病毒16 E6癌蛋白通过靶向人类ADA3共激活因子抑制视黄酸X受体介导的反式激活。
J Biol Chem. 2002 Nov 22;277(47):45611-8. doi: 10.1074/jbc.M208447200. Epub 2002 Sep 15.
3
hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells.人乳头瘤病毒16型E6介导的hAda3降解与p14ARF-p53信号通路的废除以及人乳腺上皮细胞的有效永生化相关。
J Virol. 2008 Apr;82(8):3912-20. doi: 10.1128/JVI.02466-07. Epub 2008 Feb 6.
4
Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.人类ADA3与雌激素受体(ER)结合,并作为ER介导的反式激活的共激活因子发挥作用。
J Biol Chem. 2004 Dec 24;279(52):54230-40. doi: 10.1074/jbc.M404482200. Epub 2004 Oct 20.
5
Identification of a peptide that disrupts hADA3-E6 interaction with implications in HPV induced cancer therapy.鉴定一种能破坏 hADA3-E6 相互作用的肽,这对 HPV 诱导的癌症治疗具有重要意义。
Life Sci. 2022 Jan 1;288:120157. doi: 10.1016/j.lfs.2021.120157. Epub 2021 Nov 19.
6
PKN binds and phosphorylates human papillomavirus E6 oncoprotein.PKN可结合并磷酸化人乳头瘤病毒E6癌蛋白。
J Biol Chem. 2000 May 19;275(20):14824-30. doi: 10.1074/jbc.275.20.14824.
7
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.人乳头瘤病毒16型E6癌蛋白可通过靶向转录共激活因子CBP/p300来下调p53活性。
J Virol. 1999 Aug;73(8):6209-19. doi: 10.1128/JVI.73.8.6209-6219.1999.
8
Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.通过抑制蛋白酶体依赖性降解,“高危”而非“低危”人乳头瘤病毒(HPV)E6蛋白的细胞稳态水平会升高,且这一过程与其p53和E6相关蛋白(E6AP)结合能力无关。
Virology. 2002 Jul 20;299(1):72-87. doi: 10.1006/viro.2002.1502.
9
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.p53的降解可被HPV E6序列靶向,这些序列不同于p53结合和反式激活所需的序列。
Cell. 1991 Nov 1;67(3):547-56. doi: 10.1016/0092-8674(91)90529-8.
10
Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.人乳头瘤病毒E6蛋白导致p53肿瘤抑制蛋白的同源物p73功能失活。
Int J Cancer. 2001 Mar 15;91(6):822-7. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1130>3.0.co;2-0.

引用本文的文献

1
Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?厨房里厨师太多:人乳头瘤病毒驱动的致癌作用——协作还是竞争的结果?
Tumour Virus Res. 2024 Dec 27;19:200311. doi: 10.1016/j.tvr.2024.200311.
2
The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.宫颈癌的特征:人乳头瘤病毒诱导的分子机制
Biology (Basel). 2024 Jan 27;13(2):77. doi: 10.3390/biology13020077.
3
Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis.α 和β HPV E6 癌蛋白的比较分析:对功能差异和发病机制不同机制的深入了解。
Viruses. 2023 Nov 14;15(11):2253. doi: 10.3390/v15112253.
4
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.人乳头瘤病毒相关癌症:最新知识更新。
Viruses. 2021 Nov 6;13(11):2234. doi: 10.3390/v13112234.
5
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis.不那么好、坏和丑:HPV E5、E6 和 E7 致癌蛋白在致癌作用中的协同作用。
Viruses. 2021 Sep 22;13(10):1892. doi: 10.3390/v13101892.
6
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.作为宫颈癌潜在靶向治疗药物的E6的质子泵抑制剂调节剂:靶向E6的研究进展与挑战
Molecules. 2021 May 18;26(10):3004. doi: 10.3390/molecules26103004.
7
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.人类乳头瘤病毒致癌蛋白:转化道路上靶向宿主通路的综述。
J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11.
8
A Dynamic Role of Mastermind-Like 1: A Journey Through the Main (Path)ways Between Development and Cancer.类主谋蛋白1的动态作用:探索发育与癌症之间的主要(信号)通路之旅
Front Cell Dev Biol. 2020 Dec 21;8:613557. doi: 10.3389/fcell.2020.613557. eCollection 2020.
9
The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.p53 在妇科癌症中的关联和意义:靶向治疗的潜力。
Int J Mol Sci. 2019 Nov 4;20(21):5482. doi: 10.3390/ijms20215482.
10
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells.一种定量 LumiFluo 测定法,用于检测抑制化合物对人乳头瘤病毒致癌蛋白 E6 诱导的活细胞中 p53 降解的抑制作用。
Sci Rep. 2018 Apr 16;8(1):6020. doi: 10.1038/s41598-018-24470-4.

本文引用的文献

1
The p300/CBP family: integrating signals with transcription factors and chromatin.p300/CBP 家族:将信号与转录因子和染色质整合在一起。
Trends Cell Biol. 1997 Jun;7(6):230-6. doi: 10.1016/S0962-8924(97)01048-9.
2
The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors.共激活因子和共抑制因子在类固醇激素受体生物学及作用机制中的作用。
J Mammary Gland Biol Neoplasia. 2000 Jul;5(3):307-24. doi: 10.1023/a:1009503029176.
3
Proteasome-mediated regulation of the hDlg tumour suppressor protein.蛋白酶体介导的hDlg肿瘤抑制蛋白调控
J Cell Sci. 2001 Dec;114(Pt 23):4285-92. doi: 10.1242/jcs.114.23.4285.
4
hADA3 is required for p53 activity.p53活性需要hADA3。
EMBO J. 2001 Nov 15;20(22):6404-13. doi: 10.1093/emboj/20.22.6404.
5
Dual role of p300 in the regulation of p53 stability.p300在p53稳定性调节中的双重作用。
J Biol Chem. 2001 Dec 7;276(49):45928-32. doi: 10.1074/jbc.M107770200. Epub 2001 Oct 8.
6
Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.人乳头瘤病毒16型E7癌蛋白对视网膜母细胞瘤肿瘤抑制因子的降解对于功能失活很重要,并且与E7的蛋白酶体降解可分离。
J Virol. 2001 Aug;75(16):7583-91. doi: 10.1128/JVI.75.16.7583-7591.2001.
7
Binding of p300/CBP co-activators by polyoma large T antigen.多瘤大T抗原与p300/CBP共激活因子的结合。
J Biol Chem. 2001 Sep 7;276(36):33533-9. doi: 10.1074/jbc.M102906200. Epub 2001 Jul 3.
8
p300/CBP/p53 interaction and regulation of the p53 response.p300/CBP/p53相互作用及p53反应的调控
Eur J Biochem. 2001 May;268(10):2773-8. doi: 10.1046/j.1432-1327.2001.02226.x.
9
Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells.人乳头瘤病毒16型E6诱导的E6TP1降解与其使人类乳腺上皮细胞永生化的能力相关。
J Virol. 2001 May;75(9):4459-66. doi: 10.1128/JVI.75.9.4459-4466.2001.
10
Role of T antigen interactions with p53 in tumorigenesis.T抗原与p53的相互作用在肿瘤发生中的作用。
Semin Cancer Biol. 2001 Feb;11(1):23-30. doi: 10.1006/scbi.2000.0343.

人乳头瘤病毒癌蛋白E6可使转录共激活因子人ADA3失活。

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

作者信息

Kumar Ajay, Zhao Yongtong, Meng Gaoyuan, Zeng Musheng, Srinivasan Seetha, Delmolino Laurie M, Gao Qingshen, Dimri Goberdhan, Weber Georg F, Wazer David E, Band Hamid, Band Vimla

机构信息

Division of Radiation and Cancer Biology, Department of Radiation Oncology, New England Medical Center, Boston, Massachusetts 02111, USA.

出版信息

Mol Cell Biol. 2002 Aug;22(16):5801-12. doi: 10.1128/MCB.22.16.5801-5812.2002.

DOI:10.1128/MCB.22.16.5801-5812.2002
PMID:12138191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC133989/
Abstract

High-risk human papillomaviruses (HPVs) are associated with carcinomas of the cervix and other genital tumors. The HPV oncoprotein E6 is essential for oncogenic transformation. We identify here hADA3, human homologue of the yeast transcriptional coactivator yADA3, as a novel E6-interacting protein and a target of E6-induced degradation. hADA3 binds selectively to the high-risk HPV E6 proteins and only to immortalization-competent E6 mutants. hADA3 functions as a coactivator for p53-mediated transactivation by stabilizing p53 protein. Notably, three immortalizing E6 mutants that do not induce direct p53 degradation but do interact with hADA3 induced the abrogation of p53-mediated transactivation and G(1) cell cycle arrest after DNA damage, comparable to wild-type E6. These findings reveal a novel strategy of HPV E6-induced loss of p53 function that is independent of direct p53 degradation. Given the likely role of the evolutionarily conserved hADA3 in multiple coactivator complexes, inactivation of its function may allow E6 to perturb numerous cellular pathways during HPV oncogenesis.

摘要

高危型人乳头瘤病毒(HPV)与宫颈癌及其他生殖器肿瘤相关。HPV致癌蛋白E6对于致癌转化至关重要。我们在此鉴定出酵母转录共激活因子yADA3的人类同源物hADA3,它是一种新型的E6相互作用蛋白,也是E6诱导降解的靶点。hADA3选择性地与高危型HPV E6蛋白结合,且仅与具有永生化能力的E6突变体结合。hADA3通过稳定p53蛋白发挥p53介导的反式激活共激活因子的作用。值得注意的是,三种不诱导直接p53降解但与hADA3相互作用的永生化E6突变体,在DNA损伤后诱导p53介导的反式激活和G(1)期细胞周期停滞被废除,这与野生型E6相当。这些发现揭示了一种HPV E6诱导p53功能丧失的新策略,该策略独立于直接的p53降解。鉴于进化保守的hADA3可能在多种共激活因子复合物中发挥作用,其功能失活可能使E6在HPV致癌过程中扰乱众多细胞通路。